Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Albondin, commonly referred to as Gp60, is a 60-kDa cell surface glycoprotein primarily localized on the luminal membrane of vascular endothelial cells. It functions as a high-affinity receptor for albumin, playing a critical role in the transendothelial transport (transcytosis) of albumin and its associated ligands from the intravascular compartment to the interstitial space. The binding of albumin to Gp60 initiates a signaling cascade involving the activation of Src family kinases, which subsequently phosphorylate caveolin-1, leading to the budding and fission of caveolae (Schnitzer et al., 1994; Tiruppathi et al., 1997). This receptor-mediated pathway is a major target for nanoparticle albumin-bound (nab) technology, such as nab-paclitaxel (Abraxane), which exploits Gp60 to enhance drug delivery across the blood-vessel wall and into the tumor microenvironment (Desai et al., 2006). Beyond its role in drug delivery, Gp60 is a key determinant of vascular barrier function, and its dysregulation is associated with increased vascular permeability in inflammatory conditions and solid tumors (Minshall et al., 2002).
Albondin (Gp60) facilitates the transcytosis of albumin and albumin-bound drugs across the vascular endothelium by triggering a Src kinase-dependent signaling pathway that induces caveolae formation (Schnitzer et al., 1994; Tiruppathi et al., 1997).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Albondin (Gp60) (Gp60).